Boston Birth Cohort Study
Launched by JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH · Jul 21, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Boston Birth Cohort Study is a research project that looks at how different early life experiences can affect the health of both mothers and their children. The goal of the study is to better understand how factors during pregnancy and shortly after birth can lead to health problems later in life. This study is currently recruiting participants, and it welcomes all genders, focusing on mothers who have a single live birth at Boston Medical Center. However, mothers who have had pregnancies involving fertility treatments, twins or more, or significant birth defects are not eligible to participate.
If you join the study, you can expect to provide information about your pregnancy and your baby's health. The study aims to gather valuable insights that could help improve maternal and child health outcomes in the future. Your participation could play a crucial role in understanding how early life factors impact health, which is important for developing better care and support for families.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Mothers who deliver singleton live births at Boston Medical Center are eligible for the study.
- Exclusion Criteria:
- • pregnancies that are a result of in vitro fertilization or that involve multiple gestations, fetal chromosomal abnormalities or major birth defects.
About Johns Hopkins Bloomberg School Of Public Health
The Johns Hopkins Bloomberg School of Public Health is a leading institution dedicated to advancing public health research and education. Renowned for its rigorous academic programs and commitment to improving global health outcomes, the School conducts innovative clinical trials that address pressing health challenges. With a focus on evidence-based practices, multidisciplinary collaboration, and community engagement, the Bloomberg School leverages its extensive resources and expertise to contribute to the development of effective public health interventions and policies. Through its research endeavors, the School aims to enhance population health and inform health policy both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Xiaobin Wang, MD, ScD
Principal Investigator
Johns Hopkins Bloomberg School of Public Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials